Table 5 Average annual and age-standardized incidence per period1 of five principal malignant neoplasms in children served by IMSS and residing in the jurisdictions of Mexico City, State of Mexico, Morelos, and Puebla
Age group (years) | Sex | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Diagnostic group | <1 | 1–4 | 5–9 | 10–14 | M | F | AAI | AAS | M/F2 |
México City 92-02 (cases) | n = 44 | n = 266 | n = 220 | n = 204 | n = 392 | n = 342 | n = 734 | n = 734 | 392/342 |
1. Leukemias | 37.3 | 78.9 | 50.7 | 40.4 | 58.2 | 49.9 | 54.1 | 55.4 | 1.2 |
2. CNS tumors | 10.6 | 18.2 | 15.6 | 17.3 | 16.2 | 16.9 | 16.5 | 16.5 | 1.0 |
3. Lymphomas | 0.0 | 13.1 | 16.1 | 17.8 | 20.8 | 8.6 | 14.8 | 14.4 | 2.5 |
- Hodgkin lymphomas | 0.0 | 1.3 | 2.9 | 7.9 | 5.9 | 1.7 | 3.9 | 3.6 | 3.6 |
- Non Hodgkin lymphomas | 0.0 | 11.9 | 13.2 | 10.0 | 14.9 | 6.9 | 11.0 | 10.8 | 2.3 |
4. Germ cell tumors | 18.6 | 7.5 | 2.4 | 11.0 | 6.6 | 8.6 | 7.6 | 7.7 | 0.8 |
5. Soft-tissue Sarcomas | 5.3 | 10.0 | 7.3 | 4.2 | 4.6 | 9.3 | 6.9 | 7.1 | 0.5 |
Total | 117.1 | 166.6 | 107.4 | 106.9 | 129.6 | 117.7 | 123.8 | 126.3 | 1.1 |
State of México 96-02 (cases) | n = 44 | n = 301 | n = 234 | n = 259 | n = 446 | n = 392 | n = 838 | n = 838 | 446/392 |
1. Leucemias | 23.7 | 84.1 | 52.8 | 52.6 | 63.6 | 54.9 | 59.3 | 60.2 | 1.2 |
2. CNS tumors | 2.2 | 12.2 | 9.1 | 11.7 | 9.7 | 10.9 | 10.3 | 10.3 | 0.9 |
3. Lymphomas | 0.0 | 6.1 | 15.0 | 10.9 | 13.8 | 6.7 | 10.3 | 9.9 | 2.1 |
- Hodgkin lymphomas | 0.0 | 1.5 | 7.1 | 6.5 | 5.9 | 3.9 | 4.9 | 4.6 | 1.6 |
- Non Hodgkin lymphomas | 0.0 | 4.6 | 7.9 | 4.4 | 7.9 | 2.8 | 5.4 | 5.3 | 2.9 |
4. Germ cell tumors | 21.6 | 12.7 | 4.3 | 9.1 | 8.9 | 9.5 | 9.2 | 9.6 | 1.0 |
5. Bone Tumors | 0.0 | 1.5 | 3.2 | 15.7 | 4.3 | 8.7 | 6.5 | 6.1 | 0.5 |
Total | 94.9 | 153.4 | 92.2 | 112.7 | 120.7 | 109.8 | 115.4 | 117.3 | 1.1 |
Morelos 96-02 (cases) | n = 9 | n = 45 | n = 32 | n = 31 | n = 60 | n = 57 | n = 117 | n = 117 | 60/57 |
1. Leucemias | 0.0 | 82.2 | 73.9 | 60.2 | 64.2 | 72.5 | 68.3 | 66.8 | 0.9 |
2. Lymphomas | 0.0 | 27.4 | 14.1 | 20.1 | 32.1 | 5.2 | 19.0 | 18.9 | 6.5 |
- Hodgkin lymphomas | 0.0 | 4.6 | 3.5 | 4.0 | 7.4 | 0.0 | 3.8 | 3.7 | - |
- Non Hodgkin lymphomas | 0.0 | 22.8 | 10.6 | 16.0 | 24.7 | 5.2 | 15.2 | 15.1 | 5.0 |
3. CNS tumors | 52.2 | 22.8 | 7.0 | 8.0 | 9.9 | 18.1 | 13.9 | 15.7 | 0.6 |
4. Renal Tumors | 52.0 | 18.3 | 3.5 | 0.0 | 9.9 | 7.8 | 8.9 | 10.8 | 1.3 |
5. Bone Tumors | 0.0 | 4.6 | 7.0 | 16.0 | 4.9 | 12.9 | 8.9 | 8.3 | 0.4 |
Total | 235.1 | 205.5 | 112.6 | 124.4 | 148.2 | 147.7 | 148.0 | 154.3 | 1.1 |
Puebla 98-00 (cases) | n = 11 | n = 29 | n = 34 | n = 40 | n = 62 | n = 52 | n = 114 | n = 114 | 62/52 |
1. Leukemias | 82.0 | 86.8 | 60.4 | 69.4 | 55.4 | 88.4 | 71.6 | 72.9 | 0.6 |
2. Lymphomas | 0.0 | 9.1 | 24.9 | 40.8 | 37.8 | 10.4 | 24.3 | 22.7 | 3.8 |
- Hodgkin lymphomas | 0.0 | 4.6 | 14.2 | 20.4 | 20.1 | 5.2 | 12.8 | 11.9 | 4.0 |
- Non Hodgkin lymphomas | 0.0 | 4.6 | 10.7 | 20.4 | 17.6 | 5.2 | 11.5 | 10.8 | 3.5 |
3. CNS tumors | 0.0 | 9.1 | 17.8 | 12.3 | 12.6 | 13.0 | 12.8 | 12.1 | 0.5 |
4. Hepatic Tumors | 109.3 | 9.1 | 0.0 | 0.0 | 12.6 | 2.6 | 7.7 | 11.3 | 0.2 |
5. Germ cell tumors | 27.3 | 4.6 | 0.0 | 16.3 | 2.5 | 13.0 | 7.7 | 8.3 | 0.2 |
Total | 300.7 | 132.4 | 120.7 | 163.4 | 156.0 | 135.2 | 145.8 | 150.7 | 1.2 |